LBRX logo
LBRX NASDAQ US

LB Pharmaceuticals Inc - Common Stock

Healthcare · Pharmaceuticals Website · IPO Sep 2025
$25.69
▲ +$0.88 (+3.55%)
Vol 342K
3
Quality Score
fail
Mkt Cap
$563.2M
D/E
0.00
Beta
1.44
52W
$13–$23

Wall Street Consensus

10 analysts · Apr 2026
4
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating

Price Chart

Earnings

Beat rate: 50.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.46 $-0.45 +$0.01
Sep 2025 $-0.46 $-0.61 $-0.15

Fundamentals Trend

Metric 2024-12-31 2025-06-30 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM)
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 0.00 0.00 0.00 0.00
Current Ratio 3.56 3.78 47.60 47.60

Key Ratios

EPS (TTM)
$-3.41
52W High
$23.15
52W Low
$13.36
$13.36 52-Week Range $23.15

How does LBRX compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

LBRX AARD ACB ACRS ADIL

LBRX valuation vs Pharmaceuticals peers

P/E ratio
0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
0% below peers (2.1)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (2.0%)
vs Peers
vs Industry
Low yield

LBRX profitability vs Pharmaceuticals peers

ROE
0% below peers (-54.3%)
vs Peers
vs Industry
Top tier
Net margin
0% below peers (-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
0% below peers (-37.4%)
vs Peers
vs Industry
Top tier

LBRX financial health vs Pharmaceuticals peers

D/E ratio
0.0
100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
47.6
1317% above peers (3.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.4
53% above peers (0.9)
vs Peers
vs Industry
More volatile

LBRX fundamentals radar

LBRX Peer median Industry

LBRX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

LBRX vs peers: key metrics

Latest News

No related news yet